Cargando…

Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking

Use network pharmacology combined with molecular docking to study the effects of Simiao-Yongan Decoction (SMYAD) intervenes in Knee Osteoarthritis (KOA) related targets and signaling pathways, and explores the molecular mechanism of SMYAD in treating KOA. The active ingredients and targets of SMYAD,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Pan, Xiangyu, Wang, Junwei, Chen, Haixu, Chen, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552997/
https://www.ncbi.nlm.nih.gov/pubmed/37800753
http://dx.doi.org/10.1097/MD.0000000000035193
_version_ 1785116070819921920
author Wang, Ying
Pan, Xiangyu
Wang, Junwei
Chen, Haixu
Chen, Lan
author_facet Wang, Ying
Pan, Xiangyu
Wang, Junwei
Chen, Haixu
Chen, Lan
author_sort Wang, Ying
collection PubMed
description Use network pharmacology combined with molecular docking to study the effects of Simiao-Yongan Decoction (SMYAD) intervenes in Knee Osteoarthritis (KOA) related targets and signaling pathways, and explores the molecular mechanism of SMYAD in treating KOA. The active ingredients and targets of SMYAD, which concluded 4 traditional Chinese medicines, were screened in TCMSP, and the related gene targets of KOA were screened in the disease databases GeneCards, MalaCards, DisGeNET, and Comparative Toxicogenomics Database, and their intersection data were obtained after integration. And used Cytoscape 3.9.1, the software topologies the network diagram of “compound—drug-active ingredient-target protein-disease.” Obtains the protein-protein interaction network diagram through STRING, and enriches and analyzes the obtained core targets. Carry out molecular docking matching verification on the main active ingredients and key targets of the drug. 106 active ingredients and 175 targets were screened from SMYAD to intervene in KOA, 36 core targets were obtained through protein-protein interaction screening, and 10 key targets played an important role. The enrichment results showed that the biological process of gene ontology mainly involved positive regulation of gene expression, negative regulation of apoptosis process, and positive regulation of apoptosis process. KEGG signaling pathway mainly involves AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, hypoxia-inducible factor-1 signaling pathway, IL-17 signaling pathway. The pathway of Reactome mainly involves interleukin-4 and interleukin-13 signaling, cytokine signaling in immune system, immune system, apoptosis. Molecular docking showed that the mainly effective components of SMYAD can fully combine with TNF, IL1B, IL6, and CASP3. The results show that the main active ingredients and potential mechanism of action of SMYAD in the treatment of KOA have the characteristics of multiple targets and multiple pathways, which provides ideas and basis for further in-depth exploration of its specific mechanism.
format Online
Article
Text
id pubmed-10552997
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105529972023-10-06 Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking Wang, Ying Pan, Xiangyu Wang, Junwei Chen, Haixu Chen, Lan Medicine (Baltimore) Research Article: Observational Study Use network pharmacology combined with molecular docking to study the effects of Simiao-Yongan Decoction (SMYAD) intervenes in Knee Osteoarthritis (KOA) related targets and signaling pathways, and explores the molecular mechanism of SMYAD in treating KOA. The active ingredients and targets of SMYAD, which concluded 4 traditional Chinese medicines, were screened in TCMSP, and the related gene targets of KOA were screened in the disease databases GeneCards, MalaCards, DisGeNET, and Comparative Toxicogenomics Database, and their intersection data were obtained after integration. And used Cytoscape 3.9.1, the software topologies the network diagram of “compound—drug-active ingredient-target protein-disease.” Obtains the protein-protein interaction network diagram through STRING, and enriches and analyzes the obtained core targets. Carry out molecular docking matching verification on the main active ingredients and key targets of the drug. 106 active ingredients and 175 targets were screened from SMYAD to intervene in KOA, 36 core targets were obtained through protein-protein interaction screening, and 10 key targets played an important role. The enrichment results showed that the biological process of gene ontology mainly involved positive regulation of gene expression, negative regulation of apoptosis process, and positive regulation of apoptosis process. KEGG signaling pathway mainly involves AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, hypoxia-inducible factor-1 signaling pathway, IL-17 signaling pathway. The pathway of Reactome mainly involves interleukin-4 and interleukin-13 signaling, cytokine signaling in immune system, immune system, apoptosis. Molecular docking showed that the mainly effective components of SMYAD can fully combine with TNF, IL1B, IL6, and CASP3. The results show that the main active ingredients and potential mechanism of action of SMYAD in the treatment of KOA have the characteristics of multiple targets and multiple pathways, which provides ideas and basis for further in-depth exploration of its specific mechanism. Lippincott Williams & Wilkins 2023-10-06 /pmc/articles/PMC10552997/ /pubmed/37800753 http://dx.doi.org/10.1097/MD.0000000000035193 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article: Observational Study
Wang, Ying
Pan, Xiangyu
Wang, Junwei
Chen, Haixu
Chen, Lan
Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
title Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
title_full Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
title_fullStr Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
title_full_unstemmed Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
title_short Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
title_sort exploration of simiao-yongan decoction on knee osteoarthritis based on network pharmacology and molecular docking
topic Research Article: Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552997/
https://www.ncbi.nlm.nih.gov/pubmed/37800753
http://dx.doi.org/10.1097/MD.0000000000035193
work_keys_str_mv AT wangying explorationofsimiaoyongandecoctiononkneeosteoarthritisbasedonnetworkpharmacologyandmoleculardocking
AT panxiangyu explorationofsimiaoyongandecoctiononkneeosteoarthritisbasedonnetworkpharmacologyandmoleculardocking
AT wangjunwei explorationofsimiaoyongandecoctiononkneeosteoarthritisbasedonnetworkpharmacologyandmoleculardocking
AT chenhaixu explorationofsimiaoyongandecoctiononkneeosteoarthritisbasedonnetworkpharmacologyandmoleculardocking
AT chenlan explorationofsimiaoyongandecoctiononkneeosteoarthritisbasedonnetworkpharmacologyandmoleculardocking